hapabapa/iStock Editorial via Getty Images
Novo Nordisk (NOVO) is asking the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of drugs that can be combined.
In a Citizen Petition published on Regulations.gov, Novo Nordisk (NVO) noted